Iovance Biotherapeutics, Inc(NASDAQ:IOVA) 
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead pro...
Website: http://www.iovance.com
Founded: 2007
Full Time Employees: 148
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.18
H 3.20
L 2.95
C 3.00
V 13,924,403
10EMA 3.00
20EMA 3.00
60EMA 3.00
120EMA 3.00
250EMA 3.00